Atlas Trials

A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors

Clinical trial NCT01631279 · TERMINATED

Trial details

NCT number
NCT01631279
Sponsor
Proacta, Incorporated
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Unspecified Adult Solid Tumor, Protocol Specific
Start date
2012-08-01
Primary completion
2015-03-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.